Evidence map›Paper›PMID 39333991›Full record

ArticleBMC public health2024

Designing a model to estimate the burden of COVID-19 in Iran.

Sadegh Ghazanfari, Mohammad Meskarpour-Amiri, Sayyed-Morteza Hosseini-Shokouh, Ehsan Teymourzadeh, Parisa Mehdizadeh, Mahmood Salesi

Abstract read
In one paragraph

Article in BMC public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sadegh GhazanfariDepartment of Health Economics and Management, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0003-0130-8843
Mohammad Meskarpour-AmiriHealth Management Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.ORCID 0000-0003-4624-8434
Sayyed-Morteza Hosseini-ShokouhDepartment of Health Economics, Health Management Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-7401-7804
Ehsan TeymourzadehHealth Management Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-3238-9853
Parisa MehdizadehHealth Management Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran. p.mahdizade@gmail.com.ORCID 0000-0002-2483-4646
Mahmood SalesiChemical Injuries Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.ORCID 0000-0003-3042-2143

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The novel coronavirus disease 2019 (COVID-19) is the latest evidence of an epidemic disease resulting in an extraordinary number of infections and claimed several lives, along with extensive economic and social consequences. In response to the emergency situation, countries introduced different policies to address the situation, with different levels of efficacy. This paper outlines the protocol for developing a model to analyze the burden of COVID-19 in Iran and the effect of policies on the incidence and cumulative death of the disease. The importance of the model lies in the fact that no study, according to the authors' best knowledge, tried to quantify the impact of the disease on Iran society and the impact of various implemented interventions on disease control. Based on a systematic review of COVID-19 prediction models and expert interviews, we developed a system dynamics model that not only includes an epidemic part but also considers the impact of various policies implemented by the Ministry of Health. The epidemic model estimates the incidence and mortality of COVID-19 in Iran. The model also intends to evaluate the effect of implemented policies on these outcomes. The model reflects the continuum of COVID-19 infection and care in Iran (of which some of its elements are unique) and key activities and decisions in delivering care. The model is calibrated and validated using data published by the Ministry of Health of Iran. Finally, the study aims to provide evidence of the impact of interventions intended to curb COVID-19 in Iran. Insights provided by the model will be necessary for controlling either future waves of the disease or similar future pandemics.

Indexed as

COVID-19Cost of IllnessHealth PolicyHumansIncidenceIranSARS-CoV-2COVID-19IncidenceIranMortalitySystem dynamics

Identifiers

PMID39333991
PMCPMC11438189

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.